Insider · CIK 0001547658
William D Baird III
ceopresidentofficerdirector
Files at TSVT (2seventy bio, Inc.). First filing Jan 7, 2025, latest Mar 19, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $120k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | 2seventy bio, Inc. | $25k 5,092 shares | -0% | - | |
| 50Moderate | 2seventy bio, Inc. | $95k 32,481 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 13, 2025 | TSVT 2seventy bio, Inc. | DDisposition to issuer Common Stock | -1,002,825 | - | - | 118,209 | May 15, 2025 |
| May 13, 2025 | TSVT 2seventy bio, Inc. | UTender of shares Common Stock | -118,209 | - | - | 0 | May 15, 2025 |
| May 13, 2025 | TSVT 2seventy bio, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -182,000 | - | - | 0 | May 15, 2025 |
| May 13, 2025 | TSVT 2seventy bio, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -176,000 | - | - | 0 | May 15, 2025 |
| Mar 17, 2025 | TSVT 2seventy bio, Inc. | SOpen-market sale Common Stock | -5,092 | $4.95 | $25k | 1,121,034 | Mar 19, 2025 |
| Jan 6, 2025 | TSVT 2seventy bio, Inc. | AGrant or award Common Stock | +264,000 | $0.00 | $0 | 1,126,126 | Jan 8, 2025 |
| Jan 6, 2025 | TSVT 2seventy bio, Inc. | AGrant or award Stock Option (Right to buy)derivative | +176,000 | $0.00 | $0 | 176,000 | Jan 8, 2025 |
| Jan 3, 2025 | TSVT 2seventy bio, Inc. | SOpen-market sale Common Stock | -31,718 | $2.94 | $93k | 862,889 | Jan 7, 2025 |
| Jan 6, 2025 | TSVT 2seventy bio, Inc. | SOpen-market sale Common Stock | -763 | $2.78 | $2,120 | 862,126 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.